Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118655976 | 11865597 | 6 | F | 20151020 | 20160725 | 20151223 | 20160808 | EXP | CA-PFIZER INC-2012292491 | PFIZER | 61.00 | YR | F | Y | 0.00000 | 20160808 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118655976 | 11865597 | 1 | SS | ENBREL | ETANERCEPT | 1 | UNK | U | 0 | ||||||||||
| 118655976 | 11865597 | 2 | PS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | N | 203214 | 5 | MG | TABLET | BID | |||||
| 118655976 | 11865597 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | UNK | U | 0 | ||||||||||
| 118655976 | 11865597 | 4 | SS | ORENCIA | ABATACEPT | 1 | UNK | U | 0 | ||||||||||
| 118655976 | 11865597 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | UNK | U | 0 | ||||||||||
| 118655976 | 11865597 | 6 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | 400 MG, UNK | 0 | 400 | MG | |||||||||
| 118655976 | 11865597 | 7 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | EVERY 2 DAYS | 0 | |||||||||||
| 118655976 | 11865597 | 8 | SS | NAPROXEN. | NAPROXEN | 1 | UNK | 0 | |||||||||||
| 118655976 | 11865597 | 9 | SS | PREDNISONE. | PREDNISONE | 1 | UNK | 0 | |||||||||||
| 118655976 | 11865597 | 10 | C | METHOTREXATE. | METHOTREXATE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 118655976 | 11865597 | 11 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | UNK | 0 | |||||||||||
| 118655976 | 11865597 | 12 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 118655976 | 11865597 | 13 | C | HCQ | HYDROXYCHLOROQUINE SULFATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118655976 | 11865597 | 1 | Rheumatoid arthritis |
| 118655976 | 11865597 | 2 | Rheumatoid arthritis |
| 118655976 | 11865597 | 3 | Rheumatoid arthritis |
| 118655976 | 11865597 | 4 | Rheumatoid arthritis |
| 118655976 | 11865597 | 5 | Rheumatoid arthritis |
| 118655976 | 11865597 | 6 | Rheumatoid arthritis |
| 118655976 | 11865597 | 7 | Rheumatoid arthritis |
| 118655976 | 11865597 | 8 | Rheumatoid arthritis |
| 118655976 | 11865597 | 9 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118655976 | 11865597 | OT |
| 118655976 | 11865597 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118655976 | 11865597 | Arthropathy | |
| 118655976 | 11865597 | C-reactive protein abnormal | |
| 118655976 | 11865597 | Drug ineffective | |
| 118655976 | 11865597 | Fall | |
| 118655976 | 11865597 | Fatigue | |
| 118655976 | 11865597 | Femur fracture | |
| 118655976 | 11865597 | Osteoporosis | |
| 118655976 | 11865597 | Pain | |
| 118655976 | 11865597 | Rash | |
| 118655976 | 11865597 | Red blood cell sedimentation rate abnormal | |
| 118655976 | 11865597 | Synovitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118655976 | 11865597 | 2 | 201011 | 20151115 | 0 | |
| 118655976 | 11865597 | 6 | 2012 | 0 | ||
| 118655976 | 11865597 | 7 | 2014 | 0 | ||
| 118655976 | 11865597 | 10 | 2012 | 2014 | 0 |